Calcineurin inhibitors and proximal renal tubular injury in renal transplant patients with proteinuria and chronic allograft nephropathy

被引:15
作者
Bone, JM
Amara, AB
Shenkin, A
Hammad, A
Seffis, RA
Alexander, JL
McArdle, F
Rustom, R
机构
[1] Royal Liverpool Univ Hosp, Dept Med, Liverpool, Merseyside, England
[2] Royal Liverpool Univ Hosp, Dept Clin Chem, Liverpool, Merseyside, England
[3] Royal Liverpool Univ Hosp, Sir Peter Medawar Unit, Liverpool, Merseyside, England
关键词
N-acetyl-beta-D-glucosaminidase (NAG); proximal tubule; proteinuria; calcineurin inhibitors; chronic allograft; nephropathy;
D O I
10.1097/01.TP.0000146843.23824.93
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Chronic allograft nephropathy (CAN) is commonly associated with proteinuria. In native nephropathies, proteinuria is linked with proximal renal tubular damage. This study uses regression analysis to link proteinuria with urinary N-acetyl-beta-D-glucosaminidase (NAG) as a marker of tubular injury or hyperfunction in renal transplant patients. Methods. Proteinuria and urinary NAG were measured and regression analysis applied in 105 transplant patients (42 with CAN). Most were receiving calcineurin inhibitor-based immunosuppression (cyclosporine, n=60; tacrolimus, n=26; and neither drug, n= 19). Patients with native nephropathies (n=96) and volunteers (n= 2 1) were also studied. Results. Urinary NAG increased with increasing proteinuria. However, patients taking calcineurin inhibitors had higher urinary NAG at any level of urinary protein than those on alternative therapy, or in native nephropathies Conclusions. In groups of transplant patients taking different immunosuppressive regimens, regression analysis of urinary NAG against urinary protein can identify the separate effects of drug-related tubular injury or hyperfunction from that of proteinuria.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 16 条
[1]   Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[2]   Cyclosporine nephrotoxicity [J].
Burdmann, EA ;
Andoh, TF ;
Yu, L ;
Bennett, WM .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :465-476
[3]   Origin and significance of urinary N-acetyl-beta,D-glucosaminidase (NAG) in renal patients with proteinuria [J].
Costigan, MG ;
Rustom, R ;
Bone, JM ;
Shenkin, A .
CLINICA CHIMICA ACTA, 1996, 255 (02) :133-144
[4]   Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients [J].
Gruber, SA ;
Gallichio, M ;
Rosano, TG ;
Kaplan, SS ;
Hughes, SE ;
Urbauer, DL ;
Singh, TP ;
Lempert, N ;
Conti, DJ ;
Stein, DS ;
Drusano, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (07) :575-586
[5]   Urinary N-acetyl-β-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts [J].
Kotanko, P ;
Margreiter, R ;
Pfaller, W .
NEPHRON, 2000, 84 (03) :228-235
[6]   Association of chronic kidney graft failure with recipient blood pressure [J].
Opelz, G ;
Wujciak, T ;
Ritz, E .
KIDNEY INTERNATIONAL, 1998, 53 (01) :217-222
[7]   Chronic allograft nephropathy: An update [J].
Paul, LC .
KIDNEY INTERNATIONAL, 1999, 56 (03) :783-793
[8]   Pathophysiology of progressive nephropathies [J].
Remuzzi, G ;
Bertani, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1448-1456
[9]   Systemic and intratubular effects of cyclosporin-A and tacrolimus on the rat kidney [J].
Romano, G ;
Cavarape, A ;
Favret, G ;
Bortolotti, N ;
Bartoli, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 399 (2-3) :215-221
[10]  
RUSTOM R, 1992, MINER ELECTROL METAB, V18, P108